Scientists from the Australian Monash University have developed an experimental diabetes drug that acts on the gp130 receptor, which plays an important role in metabolism. It normalizes glucose levels, strengthens bones and reduces the proportion of fat in the body.
See also: Named new factors that cause diabetes
In type 2 diabetes, cells are known to lose their ability to absorb glucose in response to insulin secretion. As a result, blood sugar levels rise, which damages tissues and organs.
There are drugs that lower blood glucose, but they have side effects. A new drug by Australian scientists is able to burn fat without consequences for the body.
At the heart of the drug is a combination of two signaling proteins that are associated with the gp130 receptor. Hybrid artificial protein called IC7Fc.
The drug does not have negative effects on the body.
The administration of this protein to obese animals reduced their blood sugar concentration, appetite and weight.
In addition, in experimental animals increased bone mass and decreased accumulation of fat in the liver.
According to scientists, weight loss was achieved due to a decrease in the proportion of fat. None of the diabetes drugs known so far has had such a positive effect on the course of the disease and on the metabolism.
Especially effective, as scientists suggest, the drug will be for the elderly.
More news regarding treatment, medicine, nutrition, healthy living and much more – read in the Health section.